MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 108 filers reported holding MYOVANT SCIENCES LTD in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $487,005 | -56.8% | 18,064 | -71.2% | 0.00% | – |
| Q3 2022 | $1,127,000 | +104.5% | 62,764 | +41.6% | 0.00% | – |
| Q2 2022 | $551,000 | -69.5% | 44,321 | -67.3% | 0.00% | – |
| Q1 2022 | $1,807,000 | -4.4% | 135,597 | +11.6% | 0.00% | – |
| Q4 2021 | $1,891,000 | -8.2% | 121,473 | +32.3% | 0.00% | – |
| Q3 2021 | $2,060,000 | -58.9% | 91,782 | -58.3% | 0.00% | -100.0% |
| Q2 2021 | $5,017,000 | +48.1% | 220,293 | +33.8% | 0.00% | 0.0% |
| Q1 2021 | $3,388,000 | -38.6% | 164,655 | -17.6% | 0.00% | -33.3% |
| Q4 2020 | $5,517,000 | +50.8% | 199,740 | -23.3% | 0.00% | +50.0% |
| Q3 2020 | $3,659,000 | +67.8% | 260,423 | +146.1% | 0.00% | +100.0% |
| Q2 2020 | $2,181,000 | +483.2% | 105,800 | +338.2% | 0.00% | 0.0% |
| Q4 2019 | $374,000 | – | 24,145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $71,647,000 | 83.05% |
| VR Adviser, LLC | 845,000 | $17,424,000 | 4.17% |
| Opaleye Management Inc. | 682,500 | $14,073,000 | 2.84% |
| Eversept Partners, LP | 760,551 | $15,682,562 | 2.15% |
| Cormorant Asset Management, LP | 2,500,000 | $51,550,000 | 1.97% |
| Ghost Tree Capital, LLC | 300,000 | $6,186,000 | 1.63% |
| Bellevue Group AG | 4,647,000 | $95,821,000 | 1.36% |
| Aristides Capital LLC | 67,000 | $1,382,000 | 1.04% |
| Amia Capital LLP | 27,070 | $558,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 150,000 | $3,093,000 | 0.33% |